Lecture 15 - Nonlinear Pharmacokinetics and Michaelis-Menten Model

Learning Objectives

Clearly distinguish between linear and nonlinear pharmacokinetics.
Identify the specific causes of nonlinearity within the drug processes of absorption, distribution, metabolism, and excretion (ADME).
Understand the fundamental principles of the Michaelis-Menten kinetics model and its associated parameters.
Apply pharmacokinetic concepts to calculate maintenance doses, dose rates, and steady-state concentrations in clinical patients.

Comparison of Linear and Nonlinear Pharmacokinetics

Linear Pharmacokinetics (Revision of Weeks 1–7)

Proportionality: The key feature of linear pharmacokinetics is proportionality. If the dose is doubled, the resulting plasma concentration also doubles.
Kinetic Order: This occurs because all ADME processes follow first-order kinetics. Standard mathematical equations and principles in pharmacokinetics assume first-order behavior.
Principle of Superposition: If concentration versus time is plotted on a semi-log graph, the curves for different doses will overlap perfectly.
Constant Parameters: Key pharmacokinetic parameters remain constant regardless of the dose. These include: * Clearance ( $CL$ ) * Volume of Distribution ( $V_d$ ) * Bioavailability ( $F$ )
Predictability: Linear pharmacokinetics are considered predictable and dose-independent.

Nonlinear Pharmacokinetics

Complexity and Drug Handling: Things become more complex because drug-handling processes involve enzymes or transporters that have limited capacity.
Saturation: As drug concentration increases, these limited enzyme or transporter systems become saturated. Consequently, the relationship between dose and plasma concentration is no longer proportional.
Kinetic Shift: At low concentrations, the drug may follow first-order (linear) kinetics. However, as the dose increases and the system becomes limited, concentrations in the blood increase disproportionately, raising the risk of toxicity.
Dose-Concentration Curve: In a concentration vs. dose plot, linear pharmacokinetics appear as a straight line. Nonlinear kinetics match the linear path at low doses but curve upwards sharply at high doses due to system saturation.

Causes of Nonlinearity in ADME Processes

Nonlinearity occurs when one or more processes involved in drug handling becomes saturated. While drug metabolism is the most common cause, saturation affects all stages of ADME.

Absorption

Solubility and Dissolution Rate Limitation: At high doses, the gastrointestinal fluid has a limited capacity to dissolve a drug. Remaining drug stays undissolved and cannot enter the bloodstream. * Example: Greaseofulmin (also referred to as giziovalbate in the transcript).
Carrier-Mediated Transportation: Some drugs require carrier proteins for absorption. These transporters have a maximum capacity. Once saturated, extra drug remains unabsorbed.
Pre-systemic Metabolism: Gut wall or hepatic metabolism (first-pass effect) can reach saturation. If the enzymes responsible for first-pass metabolism are saturated, more drug reaches the systemic circulation than expected proportionally. * Example: Propranolol.

Distribution

Plasma Protein Binding: There is a finite number of binding sites on plasma proteins. Once saturated, more free drug remains in the plasma, leading to a disproportionate increase in plasma drug concentration. * Example: Phenylbutazone.
Tissue Binding Sites: Similar to plasma proteins, tissue binding sites can become saturated. * Examples: Thiopental and Fentanyl.
Clinical Impact: Saturation in distribution may either increase or decrease the overall drug distribution depending on which binding site is saturated.

Metabolism

Capacity-Limited Metabolism: This occurs when enzymes and cofactors become fully occupied. This is the most common cause of nonlinear kinetics. * Examples: Phenytoin and Alcohol. (e.g., excess alcohol saturates liver enzymes, leading to drowsiness).
Enzyme Induction: During long-term therapy or repeated administration, some drugs increase the activity of the enzymes that metabolize them. * Auto-induction: A drug induces its own metabolism over time, leading to lower plasma concentrations than initially seen with the same dose. * Example: Carbamazepine. This process is a common cause of both dose-dependent and time-dependent kinetics.

Excretion

Active Tubular Secretion: This process requires carrier proteins and transporters. When saturated, the drug cannot be cleared easily, leading to decreased renal clearance. * Example: Penicillin G.
Active Tubular Reabsorption: When the transporters involved in reabsorption are saturated, less drug is returned to the blood, and more is excreted in the urine. This results in increased renal clearance. * Examples: Glucose and water-soluble vitamins.
Summary of Renal Saturation: Saturation of active secretion decreases clearance, while saturation of active reabsorption increases clearance.

Characteristics of Drugs Showing Saturation Kinetics

Non-First-Order Elimination: The elimination of the drug is nonlinear and does not follow a proportional path.
Variable Half-Life ( $t_{1/2}$ ): The half-life is not constant; it typically increases as the dose increases because elimination pathways are saturated.
Disproportional AUC: The Area Under the Curve (AUC) is not proportional to the administered dose or the amount of bioavailable drug.
Challenging Drug Interactions: Different drugs may compete for the same enzyme or transporter systems, causing unpredictable increases or decreases in the metabolism of the competing drug.

Clinical Importance of Nonlinear Pharmacokinetics

Precise Dose Adjustments: Clinicians must be extremely cautious. Because the kinetics are not proportional, a small dose increase can push plasma levels into the toxic range.
Narrow Therapeutic Window: Drugs like Phenytoin require constant Therapeutic Drug Monitoring (TDM). Standard dosing is unreliable; plasma levels must be measured to ensure drug levels remain in the safe range.
Sudden Toxicity: Toxicity often occurs suddenly. Once elimination pathways saturate, the drug accumulates rapidly. A patient who appears stable can become toxic without warning.
Unpredictable Steady State: Simple rules for estimating steady-state concentrations do not apply to nonlinear drugs, making it difficult to predict final concentrations.
Variable Clearance: Clearance is not constant. As concentration increases, clearance decreases because of enzyme saturation, making the whole system unpredictable.

The Michaelis-Menten Model

Nonlinear pharmacokinetics is best described by the Michaelis-Menten equation, also known as capacity-limited metabolism or mixed-order kinetics.

Theoretical Basis

The drug binds to an enzyme to form a complex.
The complex is converted into a product (metabolite).
The enzyme is released to bind with another drug molecule.
If all enzymes are occupied, the system has reached maximum capacity.

The Michaelis-Menten Equation

$\text{Rate of decline of drug concentration}=-\frac{dC}{dt}=\frac{V_{max}\times C}{\text{Km}+C}$

$V_{max}$ : The maximum rate of the process. It represents the body's maximum elimination capacity. A higher $V_{max}$ indicates better elimination; a lower $V_{max}$ indicates lower capacity.
Km ( $K_m$ ): The Michaelis constant. It represents the drug concentration at which the elimination process works at exactly half of its maximum speed ( $V_{max}/2$ ).
Affinity: Kilometers indicates the affinity of the enzyme for the drug. It is a constant value and is not affected by changes in drug or enzyme concentration. * Low Kilometers: Indicates high affinity; saturation occurs at low concentrations. * High Kilometers: Indicates low affinity; saturation occurs only at higher concentrations.

Mathematical Behavior of the Michaelis-Menten Equation

Situation 1: When $\text{Kilometers} = C$

The rate of drug elimination is exactly half of the maximum rate ( $V_{max}/2$ ).
The elimination system works at half of its full capacity.

Situation 2: When $\text{Kilometers} \gg C$

At low doses where the drug concentration is much lower than the Michaelis constant, the denominator ( $Kilometers + C$ ) simplifies to approximately Kilometers.
The equation becomes: $-\frac{dC}{dt} = \frac{V_{max} \times C}{\text{Kilometers}}$ .
The elimination rate becomes directly dependent on concentration, following first-order kinetics. Most drugs follow this behavior at low concentrations.

Situation 3: When $\text{Kilometers} \ll C$

At high concentrations near saturation, the denominator approximates $C$ .
The equation becomes: $-\frac{dC}{dt} = V_{max}$ .
Concentrations in the numerator and denominator cancel out, and the elimination rate becomes a constant ( $V_{max}$ ). This is zero-order kinetics. The body is saturated, and increasing the drug does not increase elimination.
Examples: Phenytoin and Alcohol.

Estimation of Parameters Using Michaelis-Menten Equation

In nonlinear kinetics, parameters like clearance ( $CL$ ) and steady-state concentration ( $C_{ss}$ ) are not constant.

Clearance ( $CL$ )

$CL = \frac{\text{Elimination Rate}}{C} = \frac{V_{max}}{\text{Kilometers} + C}$

Low Concentration: If $C \ll Kilometers$ , clearance remains constant (linear).
High Concentration: If $C \gg Kilometers$ , clearance decreases significantly as concentration increases (since $C$ is in the denominator). Decreased clearance leads to drug accumulation and toxicity.

Steady State Concentration ( $C_{ss}$ ) in Multiple Dosing

At steady state, the rate of drug input equals the rate of drug elimination.

Dose Rate: $\frac{\text{Dose}}{\text{Dose Interval}}$
Equation 1: $\text{Dose Rate} = \frac{V_{max} \times C_{ss}}{\text{Kilometers} + C_{ss}}$
Equation 2 (Rearranged for $C_{ss}$ ): $C_{ss} = \frac{\text{Kilometers} \times \text{Dose Rate}}{V_{max} - \text{Dose Rate}}$